PR Newswire

Hetronifly is the world’s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC (in combination with carboplatin and…

A phased approach to integrating AI agents and assistants drives innovation, efficiency, and future-proof software development workflows  HELSINKI, Feb. 6,…

VADUZ, Liechtenstein, Feb. 6, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology…

STOCKHOLM, Feb. 6, 2025 /PRNewswire/ —  October–December 2024 Total sales MSEK 41 794 (39 542) Organic sales growth 4 percent…

$8.65 billion EBITDA for full year 2024, sees a rise of 14% year-on-year (YoY) Full year 2024 dividend of $3.41…

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ — Hansa Biopharma AB,…

NORWICH, England, Feb. 6, 2025 /PRNewswire/ — AttoSure, a premier drug and alcohol testing laboratory serving workplaces and healthcare institutions…

SENDAI, Japan, Feb. 6, 2025 /PRNewswire/ — The Miyagi Prefectural Government in northeastern Japan invited ambassadors to Japan, representatives, and…

LOS ANGELES, Feb. 6, 2025 /PRNewswire/ — Looking for a swimsuit that’s both supportive and flattering? Modlily is excited to introduce…

LONDON, Feb. 5, 2025 /PRNewswire/ — Strengthening Connectivity Solutions for Demanding Operations CSL, the leading European provider of critical IoT…

PALM BEACH GARDENS, Fla., Feb. 6, 2025 /PRNewswire/ — St. Luke’s Medical Center has achieved another significant milestone, becoming the first and…

TOKYO and  SUNNYVALE, Calif. , Feb. 5, 2025 /PRNewswire/ — Strategic technological integration between Foretellix, the leading provider of data-driven autonomy…